Dr. Anusha Lachman offers guidance in weighing up the risks and benefits and assisting practitioners to make ethical decisions when working with young people. Dr. Lachman discusses some of the ethical concerns faced when a practitioner is thinking about prescribing psychiatric medication to a child, or referring a child for psychiatric intervention. These include concerns around children as a vulnerable population, as well as the potential impact of medications on a child's developmental trajectory, including their brain development. Medications when given with sensitivity to the child's presenting difficulties and context can be very helpful in facilitating adjustment and healthy functioning. This talk is relevant to health professionals, who may consider whether to refer children for psychiatric intervention.
The Ethics of Prescribing Psychiatric Drugs To Children
Objective:
OPD Points: 5
Outline:
Dr. Lachman discusses some of the topical issues around medicating children – such as off-label prescribing and neuro-enhancers. She debates the value of giving children medication in light of their environment, and further explores the ethical principles around the age of consent, autonomy and beneficence when looking at these issues.
Content:
SectionsIntroductionThe Decision to MedicateGoodness of fitPharmacotherapyPrinciples of medical ethicsNeuro-enhancement
Presenter / Provider:
Dr. Anusha Lachman
Presenter Qualifications:
Dr. Anusha Lachman currently heads the Adolescent Psychiatric Inpatient Unit at Tygerberg Children's Hospital in Cape Town and is a joint lecturer in the Department of Psychiatry at the University of Stellenbosch. Her special interests lie in Infant Mental Health, Neuropsychiatry and First Episode Psychosis. She has published in peer review journals and been a co-author on chapters, including the on-line textbook for the International Association of Child & Adolescent Psychiatrists and Allied Professionals (IACAPAP). Amongst other notable achievements, Dr Lachman was selected as a recipient of the Donald J Cohen Fellowship and attended the leadership and mentorship program hosted by IACAPAP in 2012 in Paris, and in 2018 she presented at the World Association for Infant Mental Health Congress in Rome. She is currently involved in international collaborative projects focusing on Infant Mental Health, and Sexual & Substance Risk Behaviours in Adolescents with Mental Illness. She is interested in strengthening the field of translational research in children and adolescence and is clinically involved in promoting bench to bedside research. Dr. Lachman is involved in the First 1000 days of Life program's cross sectoral initiative since 2014 in South Africa and has culminated in the creation and recent approval of an MPhil in Infant Mental Health degree at the University of Stellenbosch. She will be the co-convenor of this degree, which is the first regulated training for infant mental health on the African continent.
Contact:
- Kyla Edinburg
- N/A
- admin@calabash.courses
Car Parking:
Disabled Parking:
Meals Included:
Meal Info:
Start / End Date
November 14, 2023
November 14, 2024